27 related articles for article (PubMed ID: 15272612)
1. Administration of secretin for autism alters dopamine metabolism in the central nervous system.
Toda Y; Mori K; Hashimoto T; Miyazaki M; Nozaki S; Watanabe Y; Kuroda Y; Kagami S
Brain Dev; 2006 Mar; 28(2):99-103. PubMed ID: 16168596
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism.
Narayan M; Srinath S; Anderson GM; Meundi DB
Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):630-5. PubMed ID: 7687150
[TBL] [Abstract][Full Text] [Related]
3. Children with autistic spectrum disorders. I: comparison of placebo and single dose of human synthetic secretin.
Levy SE; Souders MC; Wray J; Jawad AF; Gallagher PR; Coplan J; Belchic JK; Gerdes M; Mitchell R; Mulberg AE
Arch Dis Child; 2003 Aug; 88(8):731-6. PubMed ID: 12876177
[TBL] [Abstract][Full Text] [Related]
4. Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded, open-label pilot study.
Lightdale JR; Hayer C; Duer A; Lind-White C; Jenkins S; Siegel B; Elliott GR; Heyman MB
Pediatrics; 2001 Nov; 108(5):E90. PubMed ID: 11694674
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of transdermal secretin on behavior of children with autism.
Ratliff-Schaub K; Carey T; Reeves GD; Rogers MA
Autism; 2005 Jul; 9(3):256-65. PubMed ID: 15937041
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of secretin for the treatment of autism].
Toda Y; Mori K; Hashimoto T; Miyazaki M; Kuroda Y
No To Hattatsu; 2004 Jul; 36(4):289-95. PubMed ID: 15272612
[TBL] [Abstract][Full Text] [Related]
7. Secretin for the treatment of autism.
McQueen JM; Heck AM
Ann Pharmacother; 2002 Feb; 36(2):305-11. PubMed ID: 11847953
[TBL] [Abstract][Full Text] [Related]
8. Use of secretin in the treatment of childhood autism.
Kamińska B; Czaja M; Kozielska E; Mazur E; Korzon M
Med Sci Monit; 2002 Jan; 8(1):RA22-6. PubMed ID: 11782669
[TBL] [Abstract][Full Text] [Related]
9. Secretin treatment for autistic disorder: a critical analysis.
Patel NC; Yeh JY; Shepherd MD; Crismon ML
Pharmacotherapy; 2002 Jul; 22(7):905-14. PubMed ID: 12126223
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of secretin in the management of autism.
Kern JK; Espinoza E; Trivedi MH
Expert Opin Pharmacother; 2004 Feb; 5(2):379-87. PubMed ID: 14996634
[TBL] [Abstract][Full Text] [Related]
11. Secretin as a treatment for autism: a review of the evidence.
Esch BE; Carr JE
J Autism Dev Disord; 2004 Oct; 34(5):543-56. PubMed ID: 15628608
[TBL] [Abstract][Full Text] [Related]
12. Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials.
Sturmey P
Res Dev Disabil; 2005; 26(1):87-97. PubMed ID: 15590241
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
